Sector Update: Healthcare Stocks Fall Late Afternoon
MT newswire2026/09/30 20:00Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
04:00 PM EDT, 09/30/2026 (MT Newswires) -- Healthcare stocks declined late Wednesday afternoon with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each shedding 1.1%. The iShares Biotechnology ETF (IBB) rose 0.1%. In corporate news, a federal judge in Minnesota granted in part and denied in part UnitedHealth's (UNH) motion to dismiss a suit brought by the California Public Employees' Retirement System that accuses the company of violating the Securities Exchange Act and a Securities and Exchange Commission rule, a court filing showed. UnitedHealth shares fell 1.8%. Liquidia (LQDA) shares plunged 57%. A federal court in Delaware ruled that the company infringed two claims of a United Therapeutics (UTHR) patent covering the use of inhaled treprostinil to treat pulmonary hypertension associated with interstitial lung disease, including dry-powder formulations. United Therapeutics shares jumped 12%. Eli Lilly (LLY) reported positive results from a phase 2b trial of its investigational combination of eloralintide and tirzepatide in 367 obese or overweight adults with type 2 diabetes. Lilly shares fell 1.5%. Moderna (MRNA) appointed Juan Andres to the newly created role of chief operating officer, effective Monday. Separately, Citigroup downgraded Moderna stock to sell from neutral, The shares fell 5.4%.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
智通财经•2026/10/10 06:21
JPMorgan raises AbbVie target price to $300
格隆汇•2026/10/10 05:29
Crypto prices
MoreBitcoin
BTC
$82,756.59
+0.23%
Ethereum
ETH
$2,494.15
-0.15%
Tether USDt
USDT
$0.9991
-0.00%
BNB
BNB
$748.04
+0.68%
XRP
XRP
$1.41
+0.52%
USDC
USDC
$0.9998
+0.01%
Solana
SOL
$109.89
-0.73%
TRON
TRX
$0.3306
-0.44%
Hyperliquid
HYPE
$84.27
-1.66%
Zcash
ZEC
$1,224.72
+0.36%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now